Skip to main content

Call for papers - Antimicrobial resistance (AMR)

Guest Editor:

Zhi Ruan, PhD, Zhejiang University School of Medicine, China


Submission Status: Open   |   Submission Deadline: 15 September 2024


BMC Medical Genomics  is calling for submissions to our Collection on Antimicrobial resistance (AMR).

This collection is aimed at investigations into the evolution, spread and prevention of AMR. Focal research areas include AMR in healthcare settings, prevention of evolution and spread of AMR, improved use of antimicrobial drugs, and the treatment and care of AMR-affected patients. 

Meet the Guest Editor

Back to top

Zhi Ruan, PhD, Zhejiang University School of Medicine, China

Zhi Ruan is a principal investigator of microbial genomics and bioinformatics at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, China. His main research interests have been focusing on genomic epidemiological studies to elucidate the evolution and transmission mechanisms of multidrug-resistant bacterial pathogens. He has authored over 70 articles in prestigious journals such as Lancet Infectious Diseases, Lancet Microbe, Emerging Infectious Diseases, Nucleic Acids Research, and Drug Resistance Updates, and also serves as associate editors for several scientific journals.

About the Collection

BMC Medical Genomics is calling for submissions to our Collection on Antimicrobial resistance (AMR).

Antimicrobial resistance (AMR) is an increasing problem in healthcare worldwide. AMR occurs when microorganisms change over time to no longer respond to treatment of infections with established drugs. AMR threatens the effective prevention of infections, and thus especially those most vulnerable to infections. International organisations, including the World Health Organization and the European Commission, highlight the importance of research into evolution and prevention of AMR. 

This collection is aimed at investigations into the evolution, spread and prevention of AMR. Focal research areas include AMR in healthcare settings, prevention of evolution and spread of AMR, improved use of antimicrobial drugs, and the treatment and care of AMR-affected patients. 

Image credit: TopMicrobialStock

  1. Escherichia coli is known to cause about 2 million deaths annually of which diarrhea infection is leading and typically occurs in children under 5 years old. Although Africa is the most affected region there is l...

    Authors: Livin E. Kanje, Happiness Kumburu, Davis Kuchaka, Mariana Shayo, Masoud A. Juma, Patrick Kimu, Melkiory Beti, Marco van Zwetselaar, Boaz Wadugu, Blandina T. Mmbaga, Sixbert Isdory Mkumbaye and Tolbert Sonda
    Citation: BMC Medical Genomics 2024 17:110
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Antimicrobial resistance (AMR)" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.